BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 26026972)

  • 1. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
    Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
    Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-Positive
    Park KS; Kim DR; Baek JY; Shin A; Kim KR; Park H; Son S; Cho H; Kim YJ
    J Korean Med Sci; 2023 Dec; 38(48):e361. PubMed ID: 38084025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing
    Mofolorunsho KC; Ocheni HO; Aminu RF; Omatola CA; Olowonibi OO
    Afr Health Sci; 2021 Jun; 21(2):505-512. PubMed ID: 34795702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).
    Lai B; Zheng B; Li Y; Zhu S; Tong Z
    BMC Infect Dis; 2014 Feb; 14():66. PubMed ID: 24502648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
    He XT; Chang CN; Yu CH; Wang CC
    Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
    Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya.
    Abujnah AA; Zorgani A; Sabri MA; El-Mohammady H; Khalek RA; Ghenghesh KS
    Libyan J Med; 2015; 10(1):26412. PubMed ID: 25651907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
    Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of plasmid-mediated quinolone resistance in escherichia coli strains producing extended-spectrum beta-lactamases isolated from faeces and urine of pregnant women with acute cystitis.
    Sohrabi M; Fathi J; Mohebi S; Hashemizadeh Z; Kholdi S; Hadadi M; Keshavarz K; Darvishvand Z
    Mol Biol Rep; 2024 Apr; 51(1):566. PubMed ID: 38656625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households.
    Toombs-Ruane LJ; Benschop J; French NP; Biggs PJ; Midwinter AC; Marshall JC; Chan M; Drinković D; Fayaz A; Baker MG; Douwes J; Roberts MG; Burgess SA
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 33036993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].
    Kılıç SG; Öcal D; Tekeli A; Dolapçı İ
    Mikrobiyol Bul; 2023 Oct; 57(4):535-552. PubMed ID: 37885384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.
    Williams PCM; Waichungo J; Gordon NC; Sharland M; Murunga S; Kamau A; Berkley JA
    J Med Microbiol; 2019 May; 68(5):711-719. PubMed ID: 30994430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Sader HS; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1994 Dec; 20(4):203-8. PubMed ID: 7705033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance and Resistance of Community-Onset Extended-Spectrum β-Lactamase-Producing
    He C; Wu S; Wang X; Li L; Yan Z
    Surg Infect (Larchmt); 2024 Apr; 25(3):247-252. PubMed ID: 38588519
    [No Abstract]   [Full Text] [Related]  

  • 17. Wastewater from healthcare centers in Burkina Faso is a source of ESBL, AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae.
    Garba Z; Bonkoungou IOJ; Millogo NO; Natama HM; Vokouma PAP; Bonko MDA; Karama I; Tiendrebeogo LAW; Haukka K; Tinto H; Sangaré L; Barro N
    BMC Microbiol; 2023 Nov; 23(1):351. PubMed ID: 37978428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance and AmpC production in ESBL-producing Klebsiella pneumoniae and Klebsiella quasipneumoniae: A retrospective study in Japanese clinical isolates.
    Watanabe N; Watari T; Otsuka Y; Ito M; Yamagata K; Fujioka M
    PLoS One; 2024; 19(5):e0303353. PubMed ID: 38743684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of
    Hirakawa H; Takita A; Sato Y; Hiramoto S; Hashimoto Y; Ohshima N; Minamishima YA; Murakami M; Tomita H
    Microbiol Spectr; 2023 Jun; 11(3):e0506922. PubMed ID: 37199605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
    Sugianli AK; Ginting F; Kusumawati RL; Pranggono EH; Pasaribu AP; Gronthoud F; Geerlings S; Parwati I; De Jong MD; Van Leth F; Schultsz C
    J Antimicrob Chemother; 2017 May; 72(5):1469-1477. PubMed ID: 28137940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.